Evaluation of Implementation of ITV-Pal Program (ITV-Pal)

November 29, 2021 updated by: Cudeca Hospice Foundation

Evaluation of Implementation Process of Tech-Volunteer Program in Palliative Care: ITV-Pal Program

How can offer support to patients and families through a volunteer caring program based on new technologies? The aim of this study is to implement and evaluate a volunteer training programme in the use of new technologies: ITV-Pal Programme to support patients facing a life-threatening illness and their families.

It will created two groups of volunteers, one group will follow the CUDECA standard training program, the other will follow the proposed intervention, ITV-Pal programme. Volunteers will be allocated randomly to each group. Second stage will consist in the implementation of the direct support to patients and families through the volunteers.

The expectation is that ITV-Pal volunteers trained will be able to increase general welfare of patients and families they care for. To test it, the quality of life of patients, families and volunteers, the quality of the dying process, and identify how new technology supports volunteer end of life care will be measure.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The inclusion of volunteers to the Team in the care of the patient and the family is continually increasing. The requests for volunteers by the Medical Care Teams have been increasing year after year by 5%, reaching about 75 requests received in 2019. 85% of these requests are assigned a volunteer and the 15% who are not assigned is because the volunteer does not have the required profile which responds to the patient's needs. These statistics show, on the one hand, the important and irreplaceable work that volunteers offer in social support to the patient and this is perceived both by the patient and their family who decide to have it, and also by the Care Team that is aware of the benefits of "non-professional" care, which also humanises palliative care. On the other hand, the volunteer is increasingly present in our society and this is positive, so that more people offer their collaboration and this in turn "normalises" their role in palliative care.

Although volunteers contribute millions of hours of work, the review of bibliography found no sufficiently robust studies to merit inclusion, and even less when associating PC volunteering and NT. As more research is needed on the impact of training and support for palliative care volunteers, this study intends to study the state of art of technophilia and technophobia among patients, relatives, volunteers and healthcare professionals in PC, and according to the results, implement and evaluate a volunteer training programme in the use of new technology to support patients dying at home and their relatives.

The best approach to evaluate the implementation process of complex intervention is the combination of quantitative and qualitative methods. Basic quantitative measures of implementation may be combined with in-depth qualitative data to provide detailed understandings of intervention functioning on a small scale. Use quantitative methods to measure key process variables and allow testing of pre-hypothesised mechanisms of impact and contextual moderators. Use qualitative methods to capture emerging changes in implementation, experiences of the intervention and unanticipated or complex causal pathways, and to generate new theory.

Quantitative approach:

  • Pragmatic cluster randomized clinical trial to test the efficacy (the unit of randomization is the volunteer and the unit of analysis is the patient/relative).
  • Before-after design for satisfaction of volunteers and HPC with the intervention and its implementation to test the effectiveness.
  • Cost-utility study from the perspective of the funder with a time horizon of one year. A detailed cost analysis including costs for the adaptation of volunteer standard course to ITVPal Programme as well as the recruitment and training costs of the volunteers will be performed.

Qualitative approach: interviews (individuals and groupal) with HPC, volunteers and with key informants of patients/relatives to test at the beginning the need and usefulness of NT, and also during the implementation process to test changes and experiences.

Study Type

Interventional

Enrollment (Anticipated)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Málaga
      • Benalmádena, Málaga, Spain, 29631
        • Recruiting
        • Fundación CUDECA
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients/relatives:

  • Over 18 years; PC patients and relatives eligible for volunteer support according to the PC team assessment.
  • Acceptance to participate in the study by signing the Informed Consent.

PC Volunteers:

- Acceptance to participate in the study by signing the Informed Consent.

Exclusion criteria

- No acceptance to participate in the study by signing the Informed Consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tech-volunteer

A complex intervention with two phases is proposed.

  • First phase: volunteers new technologies training (tech-volunteering). Volunteers will be trained in the use of NT and their interconnectivity as tools to support their volunteer work. This training will be integrated into the PC volunteer training programme.
  • Second phase: using the NT with patients and relatives.
Use of new technologies for volunteering
No Intervention: Usual volunteer
the control group will receive standard volunteer service.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distress thermometer
Time Frame: Through study completion, an average of 3 months
Distress is an unpleasant experience of a mental, physical, social, or spiritual nature. It can affect the way you think, feel, or act. Distress may make it harder to cope with having cancer, its symptoms, or its treatment. 0 no distress 10 extreme distress
Through study completion, an average of 3 months
ICECAP-SCM
Time Frame: Through study completion, an average of 15 days
The ICECAP Supportive Care Measure (ICECAP-SCM) has been developed as a tool for use in economic evaluation conducted in an end of life setting
Through study completion, an average of 15 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EuroQoL 5D-5L
Time Frame: Baseline, 15 and 30 days after inclusion.

Quality of life. five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

to describe and value health across a wide range of disease areas. They are also frequently used in research into health in the general population.

Baseline, 15 and 30 days after inclusion.
Satisfaction Volunteer Programme
Time Frame: Through study completion, an average of 12 months
Satisfaction with Volunteer Programme by a self develop questionaire
Through study completion, an average of 12 months
Service Improvement Metrics: fidelity
Time Frame: Through study completion, an average of 12 months

Success of the Infrastructure. Whether the intervention was delivered as intended:

Referral criteria/identification of patients.

Through study completion, an average of 12 months
Service Improvement Metrics: dose
Time Frame: Through study completion, an average of 12 months
Eligibility and take up of the service. The quantity of intervention implemented: Number of patients eligible for the service and number of patients who accept the service.
Through study completion, an average of 12 months
Service Improvement Metrics: reach
Time Frame: Through study completion, an average of 12 months
Spread of implementation. Whether the intended audience comes into contact with the intervention, and how: Number of wards with 'eligible' patients and number of wards where the service is implemented.
Through study completion, an average of 12 months
Heath resource use
Time Frame: Through study completion, an average of 12 months
Use of health resource during the study
Through study completion, an average of 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
PHTech questionnaire
Time Frame: Through study completion, an average of 3 months
Attitudes and feelings towards technology: Technophilia/Technophobia. six items in the two factors, techEnthusiasm and techAnxiety, 1 to 5 scale so that the TechPH index could be interpreted on a five-point response scale, ranging from 1 (fully disagree) to 5 (fully agree), where the higher the index indicates a higher level of technophilia.
Through study completion, an average of 3 months
Volunteer Motivation (VFI)
Time Frame: Baseline
A 30-item measure of motivations to volunteer. Respondents answer each item on a 7-point scale ranging from 1 (not at all important/accurate) to 7 (extremely important/accurate).
Baseline
Age
Time Frame: Baseline
Age of participant measured in years
Baseline
Sex
Time Frame: Baseline
Sex of the participant
Baseline
Educational level
Time Frame: Baseline
Maximun educational level completed of the participant
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2021

Primary Completion (Anticipated)

September 30, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

April 5, 2021

First Submitted That Met QC Criteria

May 19, 2021

First Posted (Actual)

May 25, 2021

Study Record Updates

Last Update Posted (Actual)

December 10, 2021

Last Update Submitted That Met QC Criteria

November 29, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • SR20-00841

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Palliative Care

Clinical Trials on ITV-Pal

3
Subscribe